Recurrent gene fusions in prostate cancer
First Claim
Patent Images
1. A method for detecting in a human biological sample a solute carrier family 45, member 3 (SLC45A3):
- rapidly accelerated fibrosarcoma (RAF) family member gene fusion, the method comprising;
a) forming a hybridized structure comprising;
i) a nucleic acid comprising a SLC45A3;
RAF family member gene fusion comprising a 5′
portion joined at a fusion junction to a 3′
portion, said 5′
portion of the gene fusion comprising at least 10 nucleotides from exon 1 of a SLC45A3 gene and said 3′
portion of the gene fusion comprising a human RAF kinase domain; and
ii) a detectably labeled probe specifically hybridized to said nucleic acid and spanning said fusion junction; and
b) detecting the presence of the SLC45A3;
RAF family member gene fusion in the human biological sample by detecting said hybridized structure in said human biological sample.
4 Assignments
0 Petitions
Accused Products
Abstract
The present invention relates to compositions and methods for cancer diagnosis, research and therapy, including but not limited to, cancer markers. In particular, the present invention relates to recurrent gene fusions as diagnostic markers and clinical targets for prostate cancer.
-
Citations
6 Claims
-
1. A method for detecting in a human biological sample a solute carrier family 45, member 3 (SLC45A3):
- rapidly accelerated fibrosarcoma (RAF) family member gene fusion, the method comprising;
a) forming a hybridized structure comprising; i) a nucleic acid comprising a SLC45A3;
RAF family member gene fusion comprising a 5′
portion joined at a fusion junction to a 3′
portion, said 5′
portion of the gene fusion comprising at least 10 nucleotides from exon 1 of a SLC45A3 gene and said 3′
portion of the gene fusion comprising a human RAF kinase domain; andii) a detectably labeled probe specifically hybridized to said nucleic acid and spanning said fusion junction; and b) detecting the presence of the SLC45A3;
RAF family member gene fusion in the human biological sample by detecting said hybridized structure in said human biological sample. - View Dependent Claims (2, 3, 4, 5, 6)
- rapidly accelerated fibrosarcoma (RAF) family member gene fusion, the method comprising;
Specification